{"schema_version":"secwatch.filing_event.v1","accession":"0001764013-24-000003","form_type":"8-K","ticker":"IMVT","cik":"0001764013","company_name":"Immunovant, Inc.","filed_at":"2024-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.445830+00:00","generated_at":"2026-06-07T01:37:35.745588+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Immunovant corporate presentation at J.P. Morgan Healthcare Conference; no specific details disclosed","bullets":["Immunovant presented a corporate overview at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024.","Presentation title indicates focus on autoimmune diseases: 'Targeted science, Tailored solutions for people with autoimmune disease'.","Specific pipeline data, financials, or guidance are not included in the exhibit text provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001764013-24-000003","json":"https://secwatch.observer/filing/0001764013-24-000003.json","markdown":"https://secwatch.observer/filing/0001764013-24-000003.md","text":"https://secwatch.observer/filing/0001764013-24-000003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000003/0001764013-24-000003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764013/000176401324000003/imvt-20240109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T01:37:35.745588+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}